Intelligent Bio Solutions Inc.INBS
Key ratios
FCF / Sales
-285.9%TTM
2026
-285.9%2025
-324.6%2024
-314.7%
Net margin
-294.9%TTM
2026
-294.9%
ROA
-76.2%2026
2025
-59.4%2024
-53.3%
ROE
-307.7%2026
2025
-192.9%2024
-171.7%
Revenue growth
38.1%TTM
2026
38.1%2025
-1.9%2024
147.6%
Recent news
Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance
Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth
Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification
Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System
Track INBS in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer